Topiramate Tablet, Film Coated
Product Images NDC 68788-7468

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68788-7468). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7ea951b6 B020 481f 8acc 12fb7a3a69fd 01

7ea951b6 B020 481f 8acc 12fb7a3a69fd 01
Chemical structure of topiramate, showing its molecular arrangement with oxygen, sulfur, and methyl groups as part of its composition.*
FDA Label Image

7ea951b6 B020 481f 8acc 12fb7a3a69fd 02

7ea951b6 B020 481f 8acc 12fb7a3a69fd 02
A line chart comparing cumulative rates for time to first seizure over 500 days for topiramate at 50 mg/day and 400 mg/day doses. The x-axis shows time in days and the y-axis shows cumulative rates. Two lines represent 50 mg/day (solid) and 400 mg/day (dashed), with respective sample sizes noted in the legend. A p-value of 0.0002 is displayed.*
FDA Label Image

7ea951b6 B020 481f 8acc 12fb7a3a69fd 03

7ea951b6 B020 481f 8acc 12fb7a3a69fd 03
A bar chart showing the change from baseline in average monthly migraine period rate (+SE) for placebo and topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day across two studies (Study 11 and Study 12). The chart indicates that higher doses of topiramate are associated with greater reductions in migraine rates compared to placebo, with statistical significance noted for 100 mg/day and 200 mg/day doses.*
FDA Label Image

7ea951b6 B020 481f 8acc 12fb7a3a69fd 06

7ea951b6 B020 481f 8acc 12fb7a3a69fd 06
Topiramate USP 100 mg film-coated tablet label. The label shows the product name and strength prominently with dosing instructions in English and Spanish stating 'Take as Directed' and 'Tomelo como se indica'. Manufacturer is Zydus Pharmaceuticals USA Inc. The label includes warnings, storage instructions, and blank areas for lot, batch, expiration date, and other regulatory information. The label also features the Preferred Pharmaceuticals Inc. logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.